Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S161191-1g | 1g | In stock | $17.90 | |
S161191-5g | 5g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $67.90 | |
S161191-25g | 25g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $203.90 |
Group III mGlu agonist
Synonyms | O-phospho-L-serine|Dexfosfoserine|407-41-0|phosphoserine|L-O-Phosphoserine|Fosforina|L-SOP|O-Phosphoserine|L-Phosphoserine|L-Serine O-phosphate|PHOSPHONOSERINE|3-phosphoserine|H-Ser(PO3H2)-OH|Dexfosfoserine [INN]|seriphos|L-serine-O-phosphate|O-phosphono- |
---|---|
Specifications & Purity | Moligand™, ≥98%(T) |
Biochemical and Physiological Mechanisms | Group III metabotropic glutamate receptor agonist; analog ofL-AP4. Neuroprotective against excitotoxicity in cortical cell cultures. Inhibits proliferation and enhances neuronal differentiation in progenitor cells. |
Storage Temp | Argon charged |
Shipped In | Normal |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of mGlu 4 receptor;Agonist of mGlu 6 receptor;Agonist of mGlu 7 receptor;Agonist of mGlu 8 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2S)-2-amino-3-phosphonooxypropanoic acid |
---|---|
INCHI | InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1 |
InChi Key | BZQFBWGGLXLEPQ-REOHCLBHSA-N |
Canonical SMILES | C(C(C(=O)O)N)OP(=O)(O)O |
Isomeric SMILES | C([C@@H](C(=O)O)N)OP(=O)(O)O |
PubChem CID | 68841 |
Molecular Weight | 185.07 |
Reaxy-Rn | 1726826 |
PubChem CID | 68841 |
---|---|
DrugBank Ligand | DB04522 |
ChEBI | CHEBI:15811 |
ChEMBL Ligand | CHEMBL284377 |
BindingDB Ligand | 17664 |
CAS Registry No. | 407-41-0 |
Wikipedia | Phosphoserine |
RCSB PDB Ligand | SEP |
DrugCentral Ligand | 4120 |
GPCRdb Ligand | L-serine-O-phosphate |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2422459 | Certificate of Analysis | Aug 01, 2024 | S161191 |
H2422460 | Certificate of Analysis | Aug 01, 2024 | S161191 |
H2422461 | Certificate of Analysis | Aug 01, 2024 | S161191 |
K2217775 | Certificate of Analysis | Aug 24, 2022 | S161191 |
K2217776 | Certificate of Analysis | Aug 24, 2022 | S161191 |
I1813112 | Certificate of Analysis | Jul 19, 2022 | S161191 |
I1813111 | Certificate of Analysis | Jul 19, 2022 | S161191 |
Solubility | Solvent:water, Max Conc. mg/mL: 18.51, Max Conc. mM: 100 |
---|---|
Sensitivity | Moisture sensitive. |
Specific Rotation[α] | 5° (C=2,H2O) |
Melt Point(°C) | 190°C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. |
Reaxy-Rn | 1726826 |
Merck Index | 7363 |
Starting at $162.90